TG Therapeutics
$49.912
1.17%
% are buying
Info
TG Therapeutics Inc. Company that develops treatments for patients wit B-cell malignancies and autoimmune diseases. Based in New York. Yahoo! Finance
Spread
0.38
Spread (%)
0.76%
Overnight funding - Buy
-0.05579%
Overnight funding - Sell
-0.03199%
Initial margin
20.00%
Maintenance margin
10.00%
Leverage
1:5
Expires daily
No
TG Therapeutics price is climbing
TG Therapeutics’s price has increased by 1.45% over the past 24 hours and by 20.74% over the past 7 days. What's next?What is TG Therapeutics?
TG Therapeutics (NASDAQ: TGTX) is an American biopharmaceutical company focused on leveraging leverage scientific advances in B-cell biology to develop novel patient treatments. The FDA approved its BRIUMVI drug for multiple sclerosis. The TGTX share price can depend on clinical trials, regulatory approvals, competition, healthcare policies, and investor sentiment. Partnerships, licensing agreements, and mergers and acquisitions also impact investor confidence and stock performance.
How to get started
Open an account
Register, verify, and deposit
Try unlimited demo
Practise trading risk-free
Start trading
Test your strategy for real
Why Plus500?
33+ Million
Registered customers
Listed since 2013
Trustpilot rating
19K reviews
4.2
FXEmpire
Best broker in EU
2025
FAQ
The current price of TG Therapeutics is 49.913.
Today's price range is between 47.87 and 49.913.
TG Therapeutics has changed by 1.17% today.
TG Therapeutics has 80% Buyers and 20% Sellers.
